This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatuur
Cohen JA, Barkhof F, Comi G, Hartung HP, Montalban X, et al. For the TRANSFORMS study group. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N England J Med 2010;362:402–15.
Havrdova E, Galetta S, Hutchinson M, Stefoski D, Bates D, Polman CH, et al. Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study. Lancet Neurology 2009;8(3):254–60.
Vermersch P, Kappos L, Gold R, Foley JF, Olssen T, Richman S. Clinical outcomes of natalizumab-associated progressive multifocal leukoencepha- lopathy. Neurology 2011;76(20):1697–704.
Kappos L, Radue EW, O’Conner P, Polman C, Hohlfeld R, et al. FREEDOMS study group. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N England J Med 2010;362:387–401.
Editor information
Rights and permissions
Copyright information
© 2013 Springer Media
About this chapter
Cite this chapter
Hengstman, G. (2013). Barend Wijdeveld (41). In: Hengstman, G. (eds) Multipele sclerose in beeld. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-9915-4_38
Download citation
DOI: https://doi.org/10.1007/978-90-313-9915-4_38
Publisher Name: Bohn Stafleu van Loghum, Houten
Print ISBN: 978-90-313-9914-7
Online ISBN: 978-90-313-9915-4
eBook Packages: Dutch language eBook collection